Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Single-Dose Gene Replacement Therapy Clinical Trial for Patients With Spinal Muscular Atrophy Type 1 (STRIVE-EU)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03461289
Recruitment Status : Completed
First Posted : March 12, 2018
Last Update Posted : September 23, 2020
Sponsor:
Information provided by (Responsible Party):
AveXis, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 11, 2020
Actual Study Completion Date : September 11, 2020